| Literature DB >> 26728978 |
Adama Diouf1, Abdou Badiane2, Noël Magloire Manga3, Nicole Idohou-Dossou4, Papa Salif Sow5, Salimata Wade6.
Abstract
BACKGROUND: Food insecurity in sub-Saharan Africa and malnutrition constitute the main obstacles for successful treatment of people living with HIV/AIDS (PLWH). The aim of this study was to assess the effect of consuming daily 100 g RUTF (ready-to-use therapeutic food) as supplement, on body composition, anemia and zinc status of hospitalized PLWH in Senegal.Entities:
Mesh:
Substances:
Year: 2016 PMID: 26728978 PMCID: PMC4700615 DOI: 10.1186/s12889-015-2639-8
Source DB: PubMed Journal: BMC Public Health ISSN: 1471-2458 Impact factor: 3.295
Nutrient composition of the supplement and percentage coverage of daily recommended intake
| Total | Per | % | |
|---|---|---|---|
| Intakesa | 100 kcal | Coverageb | |
| Macronutrients | |||
| Energy kcal | 567.7 | - | 25.3 |
| Protein (g) | 14.2 | 2.5 | 27.9 |
| Carbohydrate (g) | 49.3 | 8.7 | 37.9 |
| Lipids (g) | 35.8 | 6.3 | 130.1 |
| Vitamins | |||
| Vitamin A (μg) | 910 | 160.3 | 132 |
| Vitamin D (μg) | 16 | 2.8 | 320 |
| Vitamin E (mg) | 20.0 | 3.5 | 133.4 |
| Vitamin C (mg) | 53 | 9.3 | 177.7 |
| Vitamin B1 (mg) | 0.6 | 0.1 | 53.0 |
| Vitamin B2 (mg) | 1.8 | 0.3 | 150 |
| Vitamin B6 (mg) | 0.6 | 0.1 | 47.7 |
| Vitamin B12 (μg) | 1.8 | 0.3 | 75 |
| Vitamin K (μg) | 21 | 3.7 | 35 |
| Biotin (μg) | 65 | 11.4 | 216.7 |
| Folic Acid (μg) | 211.8 | 37.3 | 53.0 |
| Pantothenic acid (mg) | 3.1 | 0.5 | 62 |
| Niacin (mg) | 5.3 | 0.9 | 35.3 |
| Minerals | |||
| Calcium (mg) | 320.9 | 56.5 | 32.1 |
| Phosphorus (mg) | 403.3 | 71.0 | 57.6 |
| Potassium (mg) | 1119.9 | 197.3 | 23.8 |
| Magnesium (mg) | 95.2 | 16.8 | 39.7 |
| Zinc (mg) | 7c | 1.2 | 194 |
| Copper (mg) | 1.8 | 0.3 | 89 |
| Iron (mg) | 0.6d | 0.1 | 6.2 |
| Iodine (μg) | 110 | 19.4 | 73.3 |
| Sodium (mg) | 189.4 | 33.4 | 12.6 |
| Selenium (μg) | 30 | 5.3 | 100 |
aSupplement =100 g RUTF + 100 g rice porridge
b% nutrient coverage calculated using FAO/OMS (2002, 2004)
cZinc intake calculated based on the bioavailability of zinc in mixed diets (Hotz and Brown, 2004)
d% iron intake based on the bioavailability of iron (5 %) in the supplement (FAO/OMS, 1989)
Fig. 1Flow diagram
Clinical and nutritional status of patients at baseline
| Groups | |||
|---|---|---|---|
| Control ( | RUTF ( |
| |
| Age (y) | 42 ± 12 | 40 ± 12 | 0.800 |
| Female, % (n) | 52 (22) | 86 (13) | 0.090 |
| HIV-1, % (n) | 84 (21) | 92 (24) | 0.874 |
| ART, % (n) | 76 (19) | 73 (19) | 1.000 |
| CD4 count), | 128 ± 148 | 109 ± 165 | 0.082 |
| <200 cells/μL, % (n) | 84 (19) | 81.7 (21) | 0.725. |
| Weight (kg) | 51.4 ± 9.8 | 47.1 ± 9.4 | 0.121 |
| Height (m) | 1.72 ± 0.08 | 1.66 ± 0.50 | 0.006 |
| BMI (kg/m2) | 17.5 ± 0.6 | 16.7 ± 0.6 | 0.711 |
|
| 24 (8) | 34 (11) | 0.886 |
| TBW (kg) | 8.1 ± 2.7 | 7.7 ± 2.8 | 0.121 |
| FFM (kg) | 11.1 ± 0.4 | 10.6 ± 0.4 | 0.121 |
| BF (kg) | 39.4 ± 1.2 | 37.8 ± 1.2 | 0.651 |
| % BF | 78.0 | 78.2 | 0.789 |
| Zinc (μg/dL) | 68.1 ± 29.8 | 68.7 ± 32.4 | 0.992 |
| Zinc deficiency, % (n) | 64 (16) | 54 (14) | 0.765 |
| Hb (μg/dL) | 8.5 ± 2.0 | 8.4 ± 2.2 | 0.084 |
| Anemia, % (n) | 96 (24) | 92 (24) | 1.000 |
| Chronic infection, % (n) | 32 (8) | 31 (8) | 1.000 |
Zinc deficiency: women, PZ <70 g/dL (morning fasting) and PZ < 66 mg/dL (morning nonfasting); men, PZ <74 g/dL (morning fasting) and PZ <70 mg/dL (morning nonfasting)
Anemia: women, Hb <12 μg/dL and men Hb <14 μg/dL
Chronic infection: CRP < 5 mg/L and AGP ≥ 1 g/L
Energy, zinc, vitamin A and iron intakes and % coverage of daily recommended intake in both groups
| Sex | RDAa | Groups | ||||
|---|---|---|---|---|---|---|
| Control | RUTF | |||||
| Intakes | % coverage | Intakesb | % coverage | |||
| Energy(kcal) | Women | 2100c | 1526 | 73 | 2108 | 100 |
| Men | 2520c | 1946 | 77 | 2186 | 87 | |
| Vitamin A (μg) | Women | 500 | 534.7 | 107 | 1858 | 372 |
| Men | 600 | 1561 | 260 | 1828 | 307 | |
| Zinc (mg)d | Women | 4.9 | 3.0 | 61 | 10.4 | 212 |
| Men | 7 | 3.4 | 49 | 10.6 | 151 | |
| Iron (mg)e | Women | 19.6 | 1.8 | 9 | 2.0 | 10 |
| Men | 9.1 | 2.3 | 25 | 2.9 | 32 | |
aRDA (Recommended Dietary allowances), FAO/WHO [26, 27]
bIntakes measured in addition to the supplement (RUTF + rice porridge)
c RDA of Energy is increased by 20 % to take into account the increase of daily recommended intake for PLWH (WHO, [22])
dZinc intake calculated based on the bioavailability of zinc in mixed diets (Hotz and Brown, [50])
eIron intakes calculated by taking into account the bioavailability of iron (15 %)
Changes in body composition and biological parameters from baseline to 9 weeks in both groups
| Baseline | Discharge from hospital | 9 weeks | |||||||
|---|---|---|---|---|---|---|---|---|---|
| Control ( | RUTF ( |
| Control ( | RUTF ( |
| Control ( | RUTF ( |
| |
| Weight (kg) | 51.4 ± 9.8 | 47.1 ± 9.4a | 0.121 | 50.5 ± 9.6 | 49.3 ± 9.1 | 0.651 | 49.7 ± 8.6 | 54.2 ± 8.9b | 0.009 |
| BMI (kg/m2) | 17.5 ± 0.6 | 16.7 ± 0.6a | 0.711 | 17.3 ± 0.6 | 17.6 ± 0.6 | 0.445 | 16.6 ± 0.7 | 19.3 ± 0.6b | 0.009 |
| TBW (kg) | 8.1 ± 2.7 | 7.7 ± 2.8a | 0.121 | 7.9 ± 0.3 | 8.1 ± 0.3 | 0.650 | 7.7 ± 0.3 | 8.9 ± 0.3b | 0.011 |
| FFM (kg) | 11.1 ± 0.4 | 10.6 ± 0.4a | 0.121 | 10.8 ± 0.4 | 11.1 ± 0.4 | 0.650 | 10.5 ± 0.5 | 12.3 ± 0.4b | 0.011 |
| BF (kg) | 39.4 ± 1.2 | 37.8 ± 1.2a | 0.651 | 38.5 ± 1.4 | 39.4 ± 1.4 | 0.651 | 37.5 ± 1.5 | 43.4 ± 1.4b | 0.009 |
| % BF | 78.0 | 78.2a | 0.789 | 78.1 | 78.1 | 1.000 | 78.1 | 77.9b | 0.888 |
| Zinc (μg/dL) | 68.1 ± 29.8 | 68.7 ± 32.4 | 0.992 | 72.6 ± 41.3 | 59.0 ± 24.2 | 0.220 | 71.6 ± 19.4 | 74.3 ± 45.3 | 0.811 |
| Zinc deficiency, % (n) | 64 (16) | 54 (14) | 0.765 | 44 (11) | 65 (17) | 0.187 | 41 (7) | 65 (13) | 0.147 |
| Hb (μg/dL) | 8.5 ± 2.0d | 8.4 ± 2.2a | 0.844 | 9.7 ± 1.7 | 9.9 ± 1.9b | 0.649 | 10.0 ± 1.7e | 11.8 ± 1.5c | 0.002 |
| Anemia, % (n) | 96 (24) | 92 (24)a | 1.000 | 88 (21) | 77 (20) | 0.502 | 94 (16) | 50 (10)b | 0.003 |
Groups mean were compared by student t-test (Control vs. RUTF group)
Zinc deficiency: women, PZ <70 g/dL (morning fasting) and PZ < 66 mg/dL (morning nonfasting); men, PZ <74 g/dL (morning fasting) and PZ <70 mg/dL (morning nonfasting); Anemia: Hb <12 μg/dL (women) and <14 μg/dL (men)
a, b, a/c and b/c, d/e (p < 0.05): ANOVA for repeated measures with Bonferroni correction within group